Literature DB >> 35038339

Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma.

Alberto Picca1, Clément Desjardins1, Kévin Bihan2, Nicolas Weiss3, Amélie Guihot4, Lucia Nichelli5, Loic Feuvret6, Valérie Pourcher7, Mehdi Touat1, Caroline Dehais1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35038339      PMCID： PMC8917391          DOI： 10.1093/neuonc/noab306

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.

Authors:  Stuart A Grossman; Xiaobu Ye; Glenn Lesser; Andrew Sloan; Hetty Carraway; Serena Desideri; Steven Piantadosi
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

Review 2.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

3.  Progressive multifocal leukoencephalopathy in a patient with glioblastoma.

Authors:  Jing Wu; Lauren A Langford; Dawid Schellingerhout; Nandita Guha-Thakurta; Sudhakar Tummala; Jeffrey S Weinberg; Vinay K Puduvalli
Journal:  J Neurooncol       Date:  2010-12-01       Impact factor: 4.130

4.  Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?

Authors:  Damien Roos-Weil; Nicolas Weiss; Amélie Guihot; Madalina Uzunov; Agnès Bellanger; Bruno Eymard; David Saadoun; Caroline Houillier; Ahmed Idbaih; Sophie Demeret; Claire Deback; Véronique Leblond; Damien Galanaud; Natalia Shor; Valérie Pourcher
Journal:  J Neurol       Date:  2021-01-30       Impact factor: 4.849

Review 5.  Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.

Authors:  Irene Cortese; Daniel S Reich; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2020-11-20       Impact factor: 42.937
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.